EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a pharmaceutical company focused on commercializing its prescription Avenova® lid and lash hygiene product for the domestic eye care market, reports financial results for the three months ended March 31, 2017 and provides a business update. “Avenova product sales for the quarter increased 165% over the prior year on record unit volume from our higher-margin prescription ophthalmology channel as we continued the
Category: Business
Open-Angle Glaucoma – Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017-2018 – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Open-Angle Glaucoma – Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017” drug pipelines to their offering. Open-Angle Glaucoma – Global API Manufactur…
Hoya Reports Fourth Quarter and Full-Year Financial Results
TOKYO–(BUSINESS WIRE)–HOYA Corporation (TOKYO:7741) today announced financial results for the fourth quarter and full-year ended March 31, 2017. During the quarter, revenues increased 3.8% year on year, reaching 126,304 million yen. Pre-tax profit am…
LENSAR® accorde le contrat de distribution européenne à Teleon Surgical
ORLANDO, Floride–(BUSINESS WIRE)–LENSAR, Inc. est un leader mondial de la nouvelle génération de technologie laser femtoseconde pour la chirurgie réfractive de la cataracte. Aujourd’hui, l’entreprise annonce avoir choisi Teleon Surgical comme distributeur européen du système laser LENSAR® avec la technologie Streamline™, sa plateforme de cataracte laser femtoseconde leader de l’industrie. Cette annonce intervient alors que Topcon Europe Medical B.V. (TEM) arrête la distribution de la platefor
LENSAR® erteilt Teleon Surgical Auftrag als europäischer Vertragshändler
ORLANDO, Florida–(BUSINESS WIRE)–LENSAR, Inc., ein globaler Marktführer für Femtosekunden-Lasertechnologie der nächsten Generation für refraktive Kataraktchirurgie, kündigte heute an, Teleon Surgical als europäischen Vertragshändler des Unternehmens für seine branchenführende Femtosekundenlaser-Kataraktplattform – das LENSAR® Laser System mit Streamline™ – gewählt zu haben. Dies geschieht zu einem Zeitpunkt, zu dem Topcon Europe Medical B.V. (TEM) seine Vertriebspartnerschaft für die LENSAR-P
LENSAR® Awards Teleon Surgical European Distributor Contract
ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. announces selection of Teleon Surgical as the European distributor for the LENSAR® Laser System with Streamline™ for refractive cataract surgery.
Global Leber Congenital Amaurosis Therapeutics Pipeline Review, H1 2017 – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Leber Congenital Amaurosis – Pipeline Review, H1 2017” report to their offering. Leber congenital amaurosis is an eye disorder that primarily affects the retina, which is …
Ocular Services on Demand Announces Engaging New Continuing Education Series
MADSION, Wis.–(BUSINESS WIRE)–#continuingeducation–Ocular Services on Demand today announced the availability of an engaging new 16 hour continuing education series that focuses on the basic science that underlies ocular drug and device development.
Opsis Therapeutics Announces Scientific Advisory Board Members
MADISON, Wis.–(BUSINESS WIRE)–Opsis Therapeutics (‘Opsis’), a company developing treatments for retinal diseases, today announced the formation of its scientific advisory board (SAB). Approved by the executive leadership team, the SAB is established …
ACADIA Pharmaceuticals to Present at the Bank of America Merrill Lynch 2017 Healthcare Conference on May 16, 2017
SAN DIEGO–(BUSINESS WIRE)–ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will present at the Bank of America Merrill Lynch 2017 Healthcare Conference on Tuesday, May 16, 2017, at 10:00 a.m. Pacific Time in Las Vegas. A live webcast of ACADIA’s presentation will be accessible on the company’s website, www
Ocular Therapeutix™ Presents Additional Phase 3 Data and Patient Reported Outcomes Results for DEXTENZA™ at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix™ Presents Additional Phase 3 Data and Patient Reported Outcomes Results for DEXTENZA™ at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium
Novaliq Conducts a First-in-Class Ocular Neuropathic Pain and Anti-Inflammatory Cannabinoid Drug Development Program in Collaboration with the University of Cologne, Germany
HEIDELBERG, Germany–(BUSINESS WIRE)–#DED–Novaliq announced successful application of first-in-class ocular neuropathic pain & anti-inflammatory cannabinoid-based dry eye disease treatment approach in collaboration with University of Cologne.
Visioneering Technologies, Inc. Expands US Sales Force
ATLANTA–(BUSINESS WIRE)–Visioneering Technologies, Inc. (ASX: VTI), a US-based medical device company (‘Visioneering’ or ‘The Company’) engaged in the design, manufacture, sale and distribution of its proprietary NaturalVue® Multifocal 1 Day Contact Lenses, is pleased to announce the recent expansion of its US sales force. In line with Visioneering’s plan to broaden and accelerate its US launch of NaturalVue Multifocal Contact Lenses, they have appointed Mr. Joshua Suarez as new District Sale
Eye Care Leaders Offers Insightful Education at ASCRS/ASOA Symposium
DURHAM, N.C.–(BUSINESS WIRE)–#ascrs17–Eye Care Leaders will host a variety of speakers at their booth #1333 at ASCRS/ASOA conference. Speakers include ASCRS President, Dr. Kerry Solomon, MD, as well as Dr. Piso, Philip Isham, and others.
CheckedUp Introduces a Better Way to Wait at the American Society of Cataract and Refractive Surgery Meeting
NEW YORK–(BUSINESS WIRE)–CheckedUp a specialty point of care company, is launching CheckedUp Explorer, the new ophthalmology waiting room platform that expands its fully-integrated, multi-channel patient engagement offering
Glaukos Corporation Announces First Quarter 2017 Financial Results
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, …
Second Sight Reports First Quarter 2017 Financial Results
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today reported financial results for the three-months ended March 31, 2017. First Quarter 2017 and Recent Company Highlights: Increased implant volume to 14 Argus® II Retinal Prosthesis Systems (“Argus II”) worldwide during the first quarter of 2017 compared
Global AR & VR Smartglasses and Functional Contact Lenses Market Research Report 2017-2027 – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “AR & VR Smartglasses and Functional Contact Lenses 2017-2027” report to their offering. AR & VR Smartglasses and Functional Contact Lenses Market will be Worth Over $26 Billion by 2027. This new report is focused on how the market for AR and VR headsets is going to evolve in the next decade, based on the exciting research and developments efforts of recent years along with the high visibility some projects
Bio-Tissue Announces Global Online Purchase Availability for Cliradex Light & Website Relaunch
MIAMI–(BUSINESS WIRE)–Bio-Tissue, a business unit of TissueTech, Inc., today announced the global online availability of its newest product Cliradex Light advanced foaming eyelid cleanser on its newly redesigned website, www.cliradex.com. International purchases may be directed to Amazon Marketplace. Cliradex Light – which was launched last year and quickly realized high consumer and physician office demand – is ideal for preventative eyelid care, everyday ocular hygiene and mild-to-moderate
Ophthotech Reports First Quarter 2017 Financial and Operating Results
NEW YORK–(BUSINESS WIRE)–Ophthotech today announced financial and operating results for the first quarter ended March 31, 2017 and provided a general business update.